Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
Objective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysi...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Research in Pharmacy Practice |
Subjects: | |
Online Access: | http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=Lahiji |
id |
doaj-1da95059ef1e4bfaabd55803a5d3553e |
---|---|
record_format |
Article |
spelling |
doaj-1da95059ef1e4bfaabd55803a5d3553e2020-11-24T21:47:42ZengWolters Kluwer Medknow PublicationsJournal of Research in Pharmacy Practice2319-96442279-042X2018-01-017419519910.4103/jrpp.JRPP_18_64Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trialArian Pourmehdi LahijiMojgan MortazaviShahnaz Amani TiraniFirouzeh MoeinzadehEhsan Zarea BidakiAfsoon Emami NainiGita FaghihiArash ToghyaniZiba FarajzadeganObjective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: In this two-period, two-sequence crossover randomized clinical trial, 40 eligible subjects (CAPD patients who complained of pruritus for more than 8 weeks) were randomized to 3 g of omega-3 (n = 20) or identical placebo capsules (n = 20) for 4 weeks. After a wash-out period of 6 weeks, patients were crossed over to the alternate treatment option. Pruritus intensity was assessed using the visual analog scale (VAS) at baseline, 2-and 4-weeks post-intervention in each study period. Both patients and investigators were blinded to the study protocol. Findings: No significant carry-over effect was detected. The mean pruritus score (VAS) in the omega-3 group compared with placebo group after the first (−3.02 vs. −0.48, P < 0.001) and second (−4.09 vs. −0.43, P < 0.001) intervention periods showed higher significant decrease. Conclusion: In summary, omega-3 supplementation is an effective treatment for pruritus alleviation in CAPD patients. Further studies are needed to determine the mechanisms underlying antipruritic effects of omega-3.http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=LahijiContinuous ambulatory peritoneal dialysisend-stage renal diseaseOmega-3 supplementationpruritus |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Arian Pourmehdi Lahiji Mojgan Mortazavi Shahnaz Amani Tirani Firouzeh Moeinzadeh Ehsan Zarea Bidaki Afsoon Emami Naini Gita Faghihi Arash Toghyani Ziba Farajzadegan |
spellingShingle |
Arian Pourmehdi Lahiji Mojgan Mortazavi Shahnaz Amani Tirani Firouzeh Moeinzadeh Ehsan Zarea Bidaki Afsoon Emami Naini Gita Faghihi Arash Toghyani Ziba Farajzadegan Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial Journal of Research in Pharmacy Practice Continuous ambulatory peritoneal dialysis end-stage renal disease Omega-3 supplementation pruritus |
author_facet |
Arian Pourmehdi Lahiji Mojgan Mortazavi Shahnaz Amani Tirani Firouzeh Moeinzadeh Ehsan Zarea Bidaki Afsoon Emami Naini Gita Faghihi Arash Toghyani Ziba Farajzadegan |
author_sort |
Arian Pourmehdi Lahiji |
title |
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial |
title_short |
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial |
title_full |
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial |
title_fullStr |
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial |
title_full_unstemmed |
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial |
title_sort |
omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: a crossover randomized pilot clinical trial |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Research in Pharmacy Practice |
issn |
2319-9644 2279-042X |
publishDate |
2018-01-01 |
description |
Objective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: In this two-period, two-sequence crossover randomized clinical trial, 40 eligible subjects (CAPD patients who complained of pruritus for more than 8 weeks) were randomized to 3 g of omega-3 (n = 20) or identical placebo capsules (n = 20) for 4 weeks. After a wash-out period of 6 weeks, patients were crossed over to the alternate treatment option. Pruritus intensity was assessed using the visual analog scale (VAS) at baseline, 2-and 4-weeks post-intervention in each study period. Both patients and investigators were blinded to the study protocol. Findings: No significant carry-over effect was detected. The mean pruritus score (VAS) in the omega-3 group compared with placebo group after the first (−3.02 vs. −0.48, P < 0.001) and second (−4.09 vs. −0.43, P < 0.001) intervention periods showed higher significant decrease. Conclusion: In summary, omega-3 supplementation is an effective treatment for pruritus alleviation in CAPD patients. Further studies are needed to determine the mechanisms underlying antipruritic effects of omega-3. |
topic |
Continuous ambulatory peritoneal dialysis end-stage renal disease Omega-3 supplementation pruritus |
url |
http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=Lahiji |
work_keys_str_mv |
AT arianpourmehdilahiji omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT mojganmortazavi omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT shahnazamanitirani omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT firouzehmoeinzadeh omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT ehsanzareabidaki omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT afsoonemaminaini omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT gitafaghihi omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT arashtoghyani omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial AT zibafarajzadegan omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial |
_version_ |
1725896231329202176 |